Table 1.
Patient characteristics
| ICD (n = 18) | Without ICD (n = 18) | p value | |
|---|---|---|---|
| Age (years) | 60.4 ± 7.3 | 61.8 ± 6.4 | .53 |
| Gender (male) | 15 (83%) | 10 (56%) | .07 |
| Duration of Parkinson's disease (years) | 10.9 ± 3.6 | 12.2 ± 2.9 | .23 |
| LEDD‐DA (mg) | 157.3 ± 130.0 | 205.4 ± 162.8 | .33 |
| Total LEDD (mg) | 1124.1 ± 320.5 | 1145.9 ± 378.4 | .85 |
| UPDRS‐III (off) (/108) | 31.9 ± 12.0 | 30.8 ± 12.0 | .77 |
| UPDRS‐III (on) (/108) | 5.3 ± 4.1 | 8.8 ± 6.2 | .06 |
| Hoehn and Yahr (off) (/5) | 2.7 ± 0.8 | 2.7 ± 0.8 | .88 |
| Mattis (/144) | 138.2 ± 6.2 | 137.8 ± 5.9 | .87 |
| BDI (63) | 11.3 ± 7.4 | 8.4 ± 4.7 | .22 |
| LARS (from −36 to 36) | −24.5 ± 16.4 | −32.9 ± 4.2 | .34 |
| AFPA (/5) | 3.3 ± 1.4 | 3.4 ± 1.4 | .72 |
| Motor laterality index of the disease | 7/3/8 | 5/4/9 | .77 |
| (Right/left/bilateral) | 4 (22%) | 3 (17%) | .67 |
| Current smoking |
Note. Abbreviations: AFPA = Assessment of Professional Level; BDI = Beck Depression Inventory; LARS = Lille Apathy Rating Scale; LEDD = l‐Dopa Equivalent Daily Dose; UPDRS = Unified Parkinson's Disease Rating Scale.